Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus (Q36394345)

13 August 2017

1 reference

title

Cardiometabolic risk assessment: an approach to the prevention of cardiovascular disease and diabetes mellitus (English)

1 reference

13 August 2017

cardiovascular disease

1 reference

Abu R Vasudevan

1

1 reference

PubMed ID

16473256

13 August 2017

Christie M Ballantyne

series ordinal

2

1 reference

13 August 2017

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

2-3

1 reference

13 August 2017

7-16

1 reference

Prevalence and Trends in Obesity Among US Adults, 1999-2000

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Lessons from UK prospective diabetes study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The metabolic syndrome--a new worldwide definition

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Development of the multiple metabolic syndrome: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Components of the "metabolic syndrome" and incidence of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Waist circumference, visceral obesity, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Lifestyle changes may reverse development of the insulin resistance syndrome. The Oslo Diet and Exercise Study: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Standards of medical care in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1016%2FS1098-3597%2805%2980063-8

7 January 2021

10.1016/S1098-3597(05)80063-8

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16473256